Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

NASDAQ:MEDP

Medpace Holdings, Inc.

Last Close

388.35

01/05 20:00

Market Cap

9.15B

Beta: 1.42

Volume Today

280.96K

Avg: 394.89K

PE Ratio

33.19

PFCF: 24.04

Please Sign In To Use The Chat